The new HealthVerity: View from the Curisium CEO
Last week, HealthVerity announced its acquisition of Curisium, an innovator in cloud-based drug...
Last week, HealthVerity announced its acquisition of Curisium, an innovator in cloud-based drug...
This week’s webinar, VBA 2.0 Building and accelerating VBA for the next era, offered a deeper look...
Value-based agreements unite pharma companies and payers with a mutually beneficial payment model,...
Throughout the past quarter, we’ve announced major collaborations, built on existing partnerships...
The COVID-19 outbreak has created an unprecedented need for real-time data. As the global pandemic...
The coronavirus pandemic continues to be a disruptive force for patients and physicians across the...
Healthcare has the lowest digital ad spend among major industries today. Privacy protection laws...
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly changing the landscape of life sciences, offering powerful tools for streamlining clinical trials, optimizing drug development, and enhancing regulatory ...